CBIO vs ZVRA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

CBIO

58.4
AI Score
VS
CBIO Wins

ZVRA

46.8
AI Score

Investment Advisor Scores

CBIO

58score
Recommendation
HOLD

ZVRA

47score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CBIO ZVRA Winner
Forward P/E 0 10.6724 Tie
PEG Ratio 0 10.6667 Tie
Revenue Growth 0.0% 53.3% ZVRA
Earnings Growth 0.0% -88.4% CBIO
Tradestie Score 58.4/100 46.8/100 CBIO
Profit Margin 0.0% 42.8% ZVRA
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CBIO 1M: -22.8% · 3M: -15.6% ZVRA 1M: -18.8% · 3M: -28.5%

Current Technical Phase

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 35.6 · Price: $14.32

ZVRA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.0%), weak momentum, RSI 28

RSI (14): 28.1 · Price: $9.99

Fundamentals Snapshot

Metric CBIO ZVRA
Market Cap — —
Forward P/E -5.4 9.3
Trailing P/E — 10.9
Revenue (TTM) — —
Revenue Growth 0.0% 0.5%
Gross Margin 1.0% 1.0%
Operating Margin -14.3% 0.4%
EPS -0.14 0.93
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.